Implementing a fast-track TAVI pathway in times of COVID-19: necessity or opportunity?

To the Editor, Despite the expansion of transcatheter aortic valve implantation (TAVI) to lower-risk patients, the length of stay after TAVI remains high for an average 8 days according to the Spanish TAVI registry.1 Recently published studies have demonstrated that early discharge following balloon...

Full description

Bibliographic Details
Main Authors: Lluis Asmarats, Xavier Millán, Héctor Cubero-Gallego, Jonatan Valverde, Chi Hion Li, Dabit Arzamendi
Format: Article
Language:English
Published: Permanyer 2022-05-01
Series:REC: Interventional Cardiology (English Ed.)
Online Access:https://recintervcardiol.org/en/index.php?option=com_content&view=article&id=807
_version_ 1818241148561391616
author Lluis Asmarats
Xavier Millán
Héctor Cubero-Gallego
Jonatan Valverde
Chi Hion Li
Dabit Arzamendi
author_facet Lluis Asmarats
Xavier Millán
Héctor Cubero-Gallego
Jonatan Valverde
Chi Hion Li
Dabit Arzamendi
author_sort Lluis Asmarats
collection DOAJ
description To the Editor, Despite the expansion of transcatheter aortic valve implantation (TAVI) to lower-risk patients, the length of stay after TAVI remains high for an average 8 days according to the Spanish TAVI registry.1 Recently published studies have demonstrated that early discharge following balloon-expandable transfemoral TAVI is feasible and safe.2,3 The unprecedented demand sustained by the healthcare services during the current COVID-19 pandemic has led to redirecting assets and restricting many cardiovascular procedures to protect the limited resources available like anesthesia support, ventilators, and critical care infrastructures. The present fast-track protocol was developed in response to the COVID-19 pandemic to assess the safety and feasibility of early discharge after minimalist TAVI with either balloon-expandable or self-expanding valves in our setting. Patients undergoing transfemoral TAVI were prospectively recruited. The inclusion criteria in the fast-track pathway were based on the 3M TAVI study: femoral access eligible for percutaneous closure, body mass index < 35, low-risk aortic annulus anatomy (coronary height > 10 mm, tricuspid valve, non-severe left ventricular outflow tract calcification), ejection fraction ≥ 30%, low anticipated risk of advanced conduction disturbances (PR interval < 240 ms, absence of right bundle branch block), familial support within the first 24-48 hours. All procedures were performed...
first_indexed 2024-12-12T13:24:44Z
format Article
id doaj.art-92445dab487c4853b993a9badd113e30
institution Directory Open Access Journal
issn 2604-7322
language English
last_indexed 2024-12-12T13:24:44Z
publishDate 2022-05-01
publisher Permanyer
record_format Article
series REC: Interventional Cardiology (English Ed.)
spelling doaj.art-92445dab487c4853b993a9badd113e302022-12-22T00:23:12ZengPermanyerREC: Interventional Cardiology (English Ed.)2604-73222022-05-014215015210.24875/RECICE.M22000269Implementing a fast-track TAVI pathway in times of COVID-19: necessity or opportunity?Lluis Asmarats0Xavier Millán1Héctor Cubero-Gallego2Jonatan Valverde3Chi Hion Li4Dabit Arzamendi5Departament de Cardiologia, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, SpainDepartament de Cardiologia, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, SpainDepartament de Cardiologia, Hospital del Mar, Barcelona, SpainDepartament de Cardiologia, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, SpainDepartament de Cardiologia, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, SpainDepartament de Cardiologia, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, SpainTo the Editor, Despite the expansion of transcatheter aortic valve implantation (TAVI) to lower-risk patients, the length of stay after TAVI remains high for an average 8 days according to the Spanish TAVI registry.1 Recently published studies have demonstrated that early discharge following balloon-expandable transfemoral TAVI is feasible and safe.2,3 The unprecedented demand sustained by the healthcare services during the current COVID-19 pandemic has led to redirecting assets and restricting many cardiovascular procedures to protect the limited resources available like anesthesia support, ventilators, and critical care infrastructures. The present fast-track protocol was developed in response to the COVID-19 pandemic to assess the safety and feasibility of early discharge after minimalist TAVI with either balloon-expandable or self-expanding valves in our setting. Patients undergoing transfemoral TAVI were prospectively recruited. The inclusion criteria in the fast-track pathway were based on the 3M TAVI study: femoral access eligible for percutaneous closure, body mass index < 35, low-risk aortic annulus anatomy (coronary height > 10 mm, tricuspid valve, non-severe left ventricular outflow tract calcification), ejection fraction ≥ 30%, low anticipated risk of advanced conduction disturbances (PR interval < 240 ms, absence of right bundle branch block), familial support within the first 24-48 hours. All procedures were performed...https://recintervcardiol.org/en/index.php?option=com_content&view=article&id=807
spellingShingle Lluis Asmarats
Xavier Millán
Héctor Cubero-Gallego
Jonatan Valverde
Chi Hion Li
Dabit Arzamendi
Implementing a fast-track TAVI pathway in times of COVID-19: necessity or opportunity?
REC: Interventional Cardiology (English Ed.)
title Implementing a fast-track TAVI pathway in times of COVID-19: necessity or opportunity?
title_full Implementing a fast-track TAVI pathway in times of COVID-19: necessity or opportunity?
title_fullStr Implementing a fast-track TAVI pathway in times of COVID-19: necessity or opportunity?
title_full_unstemmed Implementing a fast-track TAVI pathway in times of COVID-19: necessity or opportunity?
title_short Implementing a fast-track TAVI pathway in times of COVID-19: necessity or opportunity?
title_sort implementing a fast track tavi pathway in times of covid 19 necessity or opportunity
url https://recintervcardiol.org/en/index.php?option=com_content&view=article&id=807
work_keys_str_mv AT lluisasmarats implementingafasttracktavipathwayintimesofcovid19necessityoropportunity
AT xaviermillan implementingafasttracktavipathwayintimesofcovid19necessityoropportunity
AT hectorcuberogallego implementingafasttracktavipathwayintimesofcovid19necessityoropportunity
AT jonatanvalverde implementingafasttracktavipathwayintimesofcovid19necessityoropportunity
AT chihionli implementingafasttracktavipathwayintimesofcovid19necessityoropportunity
AT dabitarzamendi implementingafasttracktavipathwayintimesofcovid19necessityoropportunity